The Manufacturers Life Insurance Company raised its stake in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 34.2% in the 3rd quarter, HoldingsChannel reports. The fund owned 22,996 shares of the company’s stock after buying an additional 5,859 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Avanos Medical were worth $553,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the stock. Azzad Asset Management Inc. ADV increased its holdings in shares of Avanos Medical by 8.5% in the second quarter. Azzad Asset Management Inc. ADV now owns 28,521 shares of the company’s stock valued at $568,000 after purchasing an additional 2,223 shares in the last quarter. Natixis Advisors LLC boosted its holdings in Avanos Medical by 19.5% in the second quarter. Natixis Advisors LLC now owns 18,878 shares of the company’s stock valued at $376,000 after acquiring an additional 3,077 shares during the last quarter. Paradice Investment Management LLC increased its position in Avanos Medical by 5.4% in the second quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock worth $26,791,000 after purchasing an additional 69,389 shares during the period. Quest Partners LLC bought a new stake in Avanos Medical during the 2nd quarter worth about $444,000. Finally, American Century Companies Inc. boosted its stake in shares of Avanos Medical by 12.1% in the 2nd quarter. American Century Companies Inc. now owns 82,930 shares of the company’s stock valued at $1,652,000 after purchasing an additional 8,929 shares during the last quarter. 95.17% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, StockNews.com cut shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.
Avanos Medical Trading Down 2.5 %
NYSE AVNS opened at $17.97 on Friday. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a 12 month low of $17.39 and a 12 month high of $25.36. The company has a market capitalization of $825.90 million, a PE ratio of 52.85 and a beta of 0.95. The stock has a 50-day simple moving average of $20.27 and a 200 day simple moving average of $21.43.
Avanos Medical Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles
- Five stocks we like better than Avanos Medical
- Stock Dividend Cuts Happen Are You Ready?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The 3 Best Blue-Chip Stocks to Buy Now
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.